The Boston Globe |
 Semma Therapeutics raises $114m for novel diabetes treatment
The Boston Globe Semma Therapeutics wants to develop a treatment for diabetes that would eliminate the need for insulin injections. By Jonathan Saltzman Globe Staff November 30, 2017. A Cambridge biotech seeking to develop a treatment for diabetes that would eliminate ... Semma Therapeutics Raises $114 Million Series B Financing Looking to cure Type 1 diabetes, investors front $114M to launch a pioneering human study at Semma |
from Health - Google News http://ift.tt/2ipLncJ
EmoticonEmoticon